IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
Condition:   Breast Cancer Intervention:   Radiation: IORT Sponsor:   Mount Carmel Health System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 25, 2018 Category: Research Source Type: clinical trials

Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer
Condition:   Stage IV Breast Cancer AJCC v6 and v7 Interventions:   Dietary Supplement: Dietary Intervention;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsor:   Ohio State University Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2018 Category: Research Source Type: clinical trials

Apatinib Combined With Oral Etoposide in Metastatic HER2 Negative Breast Cancer
Condition:   Breast Cancer Intervention:   Drug: apatinib+oral etoposide Sponsor:   Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2018 Category: Research Source Type: clinical trials

Ketogenic Diet and Chemotherapy in Affecting Recurrence in Patients With Stage IV Breast Cancer
Condition:   Stage IV Breast Cancer AJCC v6 and v7 Interventions:   Dietary Supplement: Dietary Intervention;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsor:   Ohio State University Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 24, 2018 Category: Research Source Type: clinical trials

Gated Radiotherapy in Left Sided Breast Cancer Patients
Conditions:   Breast Neoplasm Female;   Radiotherapy Side Effect;   Heart Diseases Intervention:   Sponsor:   Technische Universität München Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 23, 2018 Category: Research Source Type: clinical trials

Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer
Condition:   Breast Neoplasms Interventions:   Drug: Denosumab 120 mg;   Drug: Denosumab 60 mg Sponsors:   Borstkanker Onderzoek Groep;   Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 22, 2018 Category: Research Source Type: clinical trials

T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
Conditions:   HER2-positive Breast Cancer;   Breast Cancer;   Breast Cancer Stage;   Recurrent Breast Cancer;   Metastatic Breast Cancer;   HER2 Positive Breast Carcinoma Interventions:   Drug: Palbociclib;   Drug: T-DM1 Sponsors:   University of Arizona;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 21, 2018 Category: Research Source Type: clinical trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Conditions:   Bone Pain;   Breast Carcinoma Metastatic in the Bone Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Condition:   Breast Cancer Interventions:   Device: Connected device;   Behavioral: Therapeutic education Sponsors:   Centre Leon Berard;   Fondation ARC;   National Cancer Institute, France;   Fondation pour la Recherche Médicale;   Cancéropôle Lyon Auvergne Rhône-Alpes;   AG2R La Mondiale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

DS-8201a Versus Ado Trastuzumab Emtansine for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane
Condition:   Breast Cancer Interventions:   Drug: Trastuzumab deruxtecan;   Drug: Ado-trastuzumab emtansine Sponsors:   Daiichi Sankyo, Inc.;   Daiichi Sankyo Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Conditions:   Bone Pain;   Breast Carcinoma Metastatic in the Bone Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Condition:   Breast Cancer Interventions:   Device: Connected device;   Behavioral: Therapeutic education Sponsors:   Centre Leon Berard;   Fondation ARC;   National Cancer Institute, France;   Fondation pour la Recherche Médicale;   Cancéropôle Lyon Auvergne Rhône-Alpes;   AG2R La Mondiale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

DS-8201a Versus Ado Trastuzumab Emtansine for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane
Condition:   Breast Cancer Interventions:   Drug: Trastuzumab deruxtecan;   Drug: Ado-trastuzumab emtansine Sponsors:   Daiichi Sankyo, Inc.;   Daiichi Sankyo Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Conditions:   Bone Pain;   Breast Carcinoma Metastatic in the Bone Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Condition:   Breast Cancer Interventions:   Device: Connected device;   Behavioral: Therapeutic education Sponsors:   Centre Leon Berard;   Fondation ARC;   National Cancer Institute, France;   Fondation pour la Recherche Médicale;   Cancéropôle Lyon Auvergne Rhône-Alpes;   AG2R La Mondiale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Conditions:   Bone Pain;   Breast Carcinoma Metastatic in the Bone Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Condition:   Breast Cancer Interventions:   Device: Connected device;   Behavioral: Therapeutic education Sponsors:   Centre Leon Berard;   Fondation ARC;   National Cancer Institute, France;   Fondation pour la Recherche Médicale;   Cancéropôle Lyon Auvergne Rhône-Alpes;   AG2R La Mondiale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

DS-8201a Versus Ado Trastuzumab Emtansine for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane
Condition:   Breast Cancer Interventions:   Drug: Trastuzumab deruxtecan;   Drug: Ado-trastuzumab emtansine Sponsors:   Daiichi Sankyo, Inc.;   Daiichi Sankyo Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Condition:   Breast Cancer Interventions:   Device: Connected device;   Behavioral: Therapeutic education Sponsors:   Centre Leon Berard;   Fondation ARC;   National Cancer Institute, France;   Fondation pour la Recherche Médicale;   Cancéropôle Lyon Auvergne Rhône-Alpes;   AG2R La Mondiale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Conditions:   Bone Pain;   Breast Carcinoma Metastatic in the Bone Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

DS-8201a Versus Ado Trastuzumab Emtansine for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane
Condition:   Breast Cancer Interventions:   Drug: Trastuzumab deruxtecan;   Drug: Ado-trastuzumab emtansine Sponsors:   Daiichi Sankyo, Inc.;   Daiichi Sankyo Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Condition:   Breast Cancer Interventions:   Device: Connected device;   Behavioral: Therapeutic education Sponsors:   Centre Leon Berard;   Fondation ARC;   National Cancer Institute, France;   Fondation pour la Recherche Médicale;   Cancéropôle Lyon Auvergne Rhône-Alpes;   AG2R La Mondiale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Conditions:   Bone Pain;   Breast Carcinoma Metastatic in the Bone Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

DS-8201a Versus Ado Trastuzumab Emtansine for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane
Condition:   Breast Cancer Interventions:   Drug: Trastuzumab deruxtecan;   Drug: Ado-trastuzumab emtansine Sponsors:   Daiichi Sankyo, Inc.;   Daiichi Sankyo Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Conditions:   Bone Pain;   Breast Carcinoma Metastatic in the Bone Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Condition:   Breast Cancer Interventions:   Device: Connected device;   Behavioral: Therapeutic education Sponsors:   Centre Leon Berard;   Fondation ARC;   National Cancer Institute, France;   Fondation pour la Recherche Médicale;   Cancéropôle Lyon Auvergne Rhône-Alpes;   AG2R La Mondiale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

DS-8201a Versus Ado Trastuzumab Emtansine for HER2-Positive, Unresectable and/or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane
Condition:   Breast Cancer Interventions:   Drug: Trastuzumab deruxtecan;   Drug: Ado-trastuzumab emtansine Sponsors:   Daiichi Sankyo, Inc.;   Daiichi Sankyo Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Efficacy of Exercise Using Connected Activity Trackers and Therapeutic Education in Localized Breast Cancer
Condition:   Breast Cancer Interventions:   Device: Connected device;   Behavioral: Therapeutic education Sponsors:   Centre Leon Berard;   Fondation ARC;   National Cancer Institute, France;   Fondation pour la Recherche Médicale;   Cancéropôle Lyon Auvergne Rhône-Alpes;   AG2R La Mondiale Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Histamine and Bone Pain Association in Participants With Breast Cancer Metastatic in the Bone
Conditions:   Bone Pain;   Breast Carcinoma Metastatic in the Bone Interventions:   Procedure: Biospecimen Collection;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration Sponsors:   Wake Forest University Health Sciences;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 18, 2018 Category: Research Source Type: clinical trials

Adapted Physical Activity (APA) in a Breast Cancer Population.
Conditions:   Breast Neoplasms;   Exercise;   Exercise Therapy;   Insulin Resistance;   Oxidative Stress;   Microcirculation;   Quality of Life;   Atherosclerosis Intervention:   Other: Exercise Sponsor:   University Of Perugia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2018 Category: Research Source Type: clinical trials